Use of bis(amidinobenzimidazoles) in the manufacture of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/415 (2006.01)

Patent

CA 2179015

Disclosed is a method of inhibiting retroviral integrase in a subject in need of such treatment. The method comprises administering to the subject an effective retroviral integrase inhibiting amount of a bis-benzimidazole compound such as bis [5- amidino-2-benzimidazolyl] methane, 1,2-bis [5-amidino-2- benzimidazolyl] ethane, 1, 2-bis [5-amidino-2- benzimidazolyl] ethene or a pharmaceutically acceptable salt thereof. A method for combatting retroviral infections is also disclosed.

Procédé d'inhibition de l'intégrase rétrovirale chez un patient nécessitant un tel traitement, qui consite à administrer au patient une quantité efficace d'un composé bis-benzimidazole inhibant l'intégrase rétrovirale, tel que du bis[5-amidino-2-benzimidazolyl]méthane, du 1,2-bis-[5-amidino-2-benzimidazolyl]éthane, 1,2-bis[5-amidino-2-benzimidazolyl]éthène ou un sel pharmaceutiquement acceptable desdites substances. Un procédé de lutte contre les infections rétrovirales est également décrit.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of bis(amidinobenzimidazoles) in the manufacture of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of bis(amidinobenzimidazoles) in the manufacture of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bis(amidinobenzimidazoles) in the manufacture of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1784657

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.